UNLIMITED TURBO SHORT - MERCK & CO. Share Price

Certificat

HY6MB

NLBNPNL2MGX4

Real-time Euronext Paris 12:02:11 26/06/2024 BST
1.432 EUR -3.37% Intraday chart for UNLIMITED TURBO SHORT - MERCK & CO.
Current month-32.76%
1 month-18.08%
Date Price Change
26/06/24 1.432 -3.37%
25/06/24 1.482 -3.33%
24/06/24 1.533 -14.88%
21/06/24 1.801 -1.21%
20/06/24 1.823 -6.46%

Real-time Euronext Paris

Last update June 26, 2024 at 12:02 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
HY6MB
ISINNLBNPNL2MGX4
Date issued 22/01/2024
Strike 147.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.975
Lowest since issue 1.332

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus
  1. Stock Market
  2. Certificates
  3. HY6MB Certificat